1-((1H-pyrazol-4-yl)methyl)-3-(2-phenyl-[1,2,4]triazolo[1,5-a]pyridin-6-yl)urea

ID: ALA4877644

PubChem CID: 151339580

Max Phase: Preclinical

Molecular Formula: C17H15N7O

Molecular Weight: 333.36

Molecule Type: Unknown

Names and Identifiers

Canonical SMILES:  O=C(NCc1cn[nH]c1)Nc1ccc2nc(-c3ccccc3)nn2c1

Standard InChI:  InChI=1S/C17H15N7O/c25-17(18-8-12-9-19-20-10-12)21-14-6-7-15-22-16(23-24(15)11-14)13-4-2-1-3-5-13/h1-7,9-11H,8H2,(H,19,20)(H2,18,21,25)

Standard InChI Key:  OKEHMXIMPNOSOP-UHFFFAOYSA-N

Molfile:  

 
     RDKit          2D

 25 28  0  0  0  0  0  0  0  0999 V2000
    2.1049  -22.1054    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    2.8126  -21.6968    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.5203  -22.1054    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    4.2344  -21.6927    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.3972  -21.6968    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.8126  -20.8796    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.6895  -22.1054    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.9371  -22.1028    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.9393  -20.4694    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.2275  -20.8762    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.6469  -20.8802    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.6436  -21.6969    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    6.4193  -21.9524    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    6.9021  -21.2936    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.4246  -20.6310    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    7.7120  -21.2893    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    8.1167  -21.9992    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    8.9332  -21.9990    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    9.3420  -21.2904    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    8.9285  -20.5807    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    8.1135  -20.5844    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.0693  -21.7755    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.6120  -22.3828    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   -0.2035  -23.0905    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.5983  -22.9205    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  2  3  1  0
  3  4  1  0
  1  5  1  0
  2  6  2  0
  5  7  1  0
  4  8  2  0
  4 10  1  0
  8 12  1  0
 11  9  1  0
  9 10  2  0
 11 12  1  0
 12 13  1  0
 13 14  2  0
 14 15  1  0
 15 11  2  0
 14 16  1  0
 16 17  2  0
 17 18  1  0
 18 19  2  0
 19 20  1  0
 20 21  2  0
 21 16  1  0
  7 22  1  0
 22 23  2  0
 23 24  1  0
 24 25  1  0
 25  7  2  0
M  END

Alternative Forms

1. Parent:

   

   ALA4877644

   ---

Molecule Features

Natural Product: No

Oral: No

Chemical Probe: No

Parenteral: No

Molecule Type: Unknown

Topical: No

First In Class: No

Black Box: No

Chirality: No

Availability: No

Prodrug: No

Calculated Properties

Molecular Weight: 333.36

Molecular Weight (Monoisotopic): 333.1338

AlogP: 2.44

#Rotatable Bonds: 4

Polar Surface Area: 100.00

Molecular Species: NEUTRAL

HBA: 5

HBD: 3

#RO5 Violations: ┄

HBA (Lipinski): 8

HBD (Lipinski): 3

#RO5 Violations (Lipinski): ┄

CX Acidic pKa: 13.07

CX Basic pKa: 2.50

CX LogP: 2.97

CX LogD: 2.97

Aromatic Rings: 4

Heavy Atoms: 25

QED Weighted: 0.53

Np Likeness Score: -2.51

References

1. Akiu M, Tsuji T, Sogawa Y, Terayama K, Yokoyama M, Tanaka J, Asano D, Sakurai K, Sergienko E, Sessions EH, Gardell SJ, Pinkerton AB, Nakamura T..  (2021)  Discovery of 1-[2-(1-methyl-1H-pyrazol-5-yl)-[1,2,4]triazolo[1,5-a]pyridin-6-yl]-3-(pyridin-4-ylmethyl)urea as a potent NAMPT (nicotinamide phosphoribosyltransferase) activator with attenuated CYP inhibition.,  43  [PMID:33887438] [10.1016/j.bmcl.2021.128048]

Source

Source(1):

• Scientific Literature